Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Oncotherapy Plc LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.50p +1.10% 46.00p 45.00p 47.00p 46.00p 45.50p 45.50p 78,286 11:01:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Real Estate Investment & Services 0.0 -16.5 -17.6 - 89.50

Advanced Oncotherapy Share Discussion Threads

Showing 5051 to 5074 of 5400 messages
Chat Pages: Latest  204  203  202  201  200  199  198  197  196  195  194  193  Older
DateSubjectAuthorDiscuss
06/4/2018
13:56
neo26 i have seen PG´s accounts (issued in Swedish but the numbers are "international".....) and he has a net worth of at least £150m - so if that is what establish a "complete buffoon", i would certainly love to be one!!
baner
05/4/2018
21:43
MakeamillionThat fool Peter is a very erratic trader dont buy as a result of him, in a few months he will put all his stock on the bid and destroy they share price Complete buffoon..
neo26
05/4/2018
20:49
Great technology with great provenance. However, bear in mind that the last time AVO took money from China, in 2016, they had to pay every penny back after the seven Chinese contracts they had were all cancelled by the Chinese after it became obvious that AVO's plans were not on track, despite AVO's continual assurances that they were on track to treat the first patient in Harley Street by the end of 2017. I am keeping an eye on AVO but I will not be buying any shares until I am satisfied that everything really is on track this time and shareholder's money is safe.
daijavu
05/4/2018
11:22
For me a great opportunity to top up, I guess so does Peter Gyllenhammar as he has now gone over 3%. IMO it pays to follow the money and with the current pool of investors whatever the future holds all is on track. Reading between the lines of the distribution agreement news we should have extremely good news very soon! Just loving this investment.
makeamillion1
05/4/2018
10:34
Where is the TR1 from Yantai? They supposedly hold about 30% of the shares. Could it be that the shares have been issued to and are held in an Escrow account until Yantai cough up? Given the company's past performance on misleading the market over what is really going on in China, there is a very real possibility it has all fallen apart. What happened to the Blackfinch loan repayment - due on 31 Mar? Surely if they had Yantai's money this would have been repaid. No wonder the share price is tanking.
sweet karolina
04/4/2018
16:40
the £13.5m are in box today, so no risk of funds having to be sent back. the issue is really when the next £16.5m will land on AVO´s account. following this hopeful event, it is from now on only too obvious that the AVO Board needs to keep their chinese "friends" on strict diet when it comes to spending AVO´s financial resources. ideally the shares will rise towards the 100p they no doubt should be worth assuming the technical issues are under control, and then AVO can dilute the Chinese influence by placing shares with some credible institutions/strategic investors in Europe.
baner
04/4/2018
09:28
I agree with altom
scottishfield
04/4/2018
09:27
Sounds just like the last time they did a Chinese deal - all fell apart when the time came for wonga to be paid. And they repaid the Chinese. May well be caused by delays - Chinese needing to see more progress before they send funds.
igbertsponk
04/4/2018
09:10
Freddythefish Your point is most valid! AVO has repeatedly stated that YC are obliged to pay also the £16.5m - subject to them being allowed to transfer funds out of china for this purpose. I cannot imagine that the AVO BOD and its legal advisors have been so naive that they allowed YC to acquire the 30% of the share capital for only £13.5m and then skip the £16.5m with ref to the lack of an OK to transfer the funds. Obviously the share holders should be provided with much clearer information on this subject.
baner
04/4/2018
09:10
Freddythefish Your point is most valid! AVO has repeatedly stated that YC are obliged to pay also the £16.5m - subject to them being allowed to transfer funds out of china for this purpose. I cannot imagine that the AVO BOD and its legal advisors have been so naive that they allowed YC to acquire the 30% of the share capital for only £13.5m and then skip the £16.5m with ref to the lack of an OK to transfer the funds. Obviously the share holders should be provided with much clearer information on this subject.
baner
04/4/2018
07:55
Seems to me to be confirmation that, although YC are behind schedule, they are not trying to weasel out of their commitment to invest. I hope!
altom
04/4/2018
02:01
My question is, why do AVO need assurance that Yantai Cipu are committed to the contract to invest in AVO? Surely a contract is a contract.... unless it isn't.
freddythefish
03/4/2018
18:43
I suspect this is long term, for experienced holders. I don’t think anyone can expect immediate gains but I certainly hold for long term (big) gains.
paul_98
03/4/2018
13:14
The rns is good (is it not?), so why the drop?
scottishfield
28/3/2018
11:52
Agreed. Will kick on properly when the news comes. GLA.
paul_98
27/3/2018
20:49
The share price movements are unimportant until we get news because, until then, the share price could just as easily drop as go up.
daijavu
27/3/2018
11:29
Very welcome rise. I feel confident that this will be further enhanced upon finance confirmation.
paul_98
26/3/2018
15:37
welcome rise after so long, if it holds.
scottishfield
16/3/2018
16:28
Sure its "on track" its easy to stay on track if you keep moving the goal posts, the timeline has been slipping since at least - RNS 29 SEPT 14 "Early milestones met to ensure the delivery of the first system in 2016", however I don't think that's surprising or particularly worrying, I wonder how many projects as complex as this are delivered on time? My worry is that this is taken over before it shows its true potential, in which case the pi , after showing so much patience will miss out.
cosmicboy
16/3/2018
14:26
makeamillion1. The timeline is drifting and not for the first time. AVO were claiming in 2016 that they were on track to treat the first patient in 2017 when they were obviously way behind. As a result, I consider it unwise to rely on the BoD's word that they are on track. Especially when there are two different sets of dates in circulation from the BoD.
daijavu
16/3/2018
14:11
Hi twirl, agreed, I should have said no inconsistency regarding time lines at all. All is on track
makeamillion1
16/3/2018
12:44
makeamillion1>>; pl explain where I said the timeline was drifting. I merely pointed out inconsistency re Harley St statements.
twirl
16/3/2018
11:32
Daijavu & twirl, FYI nothing is drifting, the company have consistently advised all is on track. The Hardman report confirms the time line presented to investors in March 2017. Importantly first patient treatment in H2 2020 but I believe most significant progress will be in Q3 2018 when due to be treating superficial tumors.
makeamillion1
15/3/2018
07:21
It is concerning that the date of first treatment keeps drifting further into the future.
daijavu
Chat Pages: Latest  204  203  202  201  200  199  198  197  196  195  194  193  Older
Your Recent History
LSE
AVO
Advanced O..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190527 06:04:31